The two companies that make vaccines against cervical cancer announced Thursday that they would cut their prices to the world’s poorest countries below $5 per dose, eventually making it possible for millions of girls to be protected against a major deadly cancer.
14 May 2013 | New York Times
As a head and neck cancer surgeon, Michael Stadler never thought he'd have to ask his patients about their sexual practices. Thirty years ago, most cancers he treated were linked to smoking. Today, 60% to 80% of oropharyngeal (tonsil and back of the tongue) cancers are linked to oral sex and genital human papillomavirus, or HPV.
10 May 2013 | Milwaukee Journal-Sentinel
A study by researchers at the University of North Carolina at Chapel Hill suggests that training women to self-collect genital samples to test for human papillomavirus, the causative agent of cervical cancer, can increase the coverage rates of cervical cancer screening.
02 May 2013 | Eurekalert Medicine & Health
Performing random anal biopsies increases the rate of diagnosis of high-grade squamous intraepithelial lesions (HSIL) during high-resolution anoscopy, researchers from Mt. Sinai School of Medicine in New York City reported at the recent 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013).
11 April 2013 | HIVandhepatitis.com
Women with HIV acquire cancer-causing forms of the human papillomavirus that are not included in the current HPV vaccines Gardasil and Cervarix, according to new research from Fox Chase Cancer Center being presented at the AACR Annual Meeting 2013 on Sunday, April 7.
08 April 2013 | Eurekalert Medicine & Health
People infected with chronic hepatitis C are less likely to develop liver cancer if they are taking cholesterol-lowering drugs, new research from Taiwan suggests.
22 March 2013 | Reuters
HIV-positive women are living longer, but are now dying of cervical cancer. In Zimbabwe, cervical cancer is now the most common cancer among women, particularly those living with HIV. Activists are urging the government to step up efforts to prevent deaths related to the disease, accusing it of paying lip service to the problem.
08 February 2013 | IRIN Plus News
The GAVI global vaccines group is to help protect more than 180,000 girls in eight countries across Africa and Asia from cervical cancer by funding immunization projects with vaccines from Merck and GlaxoSmithKline.
04 February 2013 | Reuters
HIV-positive patients have a higher incidence of non-melanoma skin cancers, according to a Kaiser Permanente study that appears in the current online issue of the Journal of the National Cancer Institute. Specifically, basal cell and squamous cell carcinomas occur more than twice as often among HIV-positive individuals compared to those who are HIV-negative.
31 January 2013 | HIV / AIDS News From Medical News Today
The best approach to detecting cervical cancer in HIV-positive women living in research limited countries such as those in Sub-Saharan Africa combines commonly used testing methods tailored to local levels of development and medical infrastructure, according to a study by researchers from and the University of Witwatersrand in South Africa and the University of North Carolina.
16 January 2013 | HIV / AIDS News From Medical News Today